Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.16−0.01 (-7.03%)
Close on Nov 12, 2026Market cap $120.89KP/E –Yield –
Endovia Health Sciences gross margin
Gross margin is gross profit as a percentage of revenue.
Endovia Health Sciences's gross margin for the twelve months ending Sep 30, 2025 was -59.9%. For fiscal 2025 it was 23.1%, against -15.0% the year before. The highest annual figure on record is 57.7% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23.1% | +38.1 |
| FY2024 | Dec 31, 2024 | -15.0% | −44.5 |
| FY2023 | Dec 31, 2023 | 29.5% | −3.2 |
| FY2022 | Dec 31, 2022 | 32.7% | −1.9 |
| FY2021 | Dec 31, 2021 | 34.6% | +18.8 |
| FY2020 | Dec 31, 2020 | 15.8% | +1120.0 |
| FY2019 | Dec 31, 2019 | -1104.2% | −1158.0 |
| FY2018 | Dec 31, 2018 | 53.8% | +3.0 |
| FY2017 | Dec 31, 2017 | 50.8% | −1.3 |
| FY2016 | Dec 31, 2016 | 52.1% | −0.3 |
| FY2015 | Dec 31, 2015 | 52.4% | −5.3 |
| FY2014 | Dec 31, 2014 | 57.7% | +7.5 |
| FY2013 | Dec 31, 2013 | 50.3% | −7.3 |
| FY2012 | Dec 31, 2012 | 57.6% | +8.9 |
| FY2011 | Dec 31, 2011 | 48.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | 43.8% | +183.5 |
| Q3 FY2025 | Sep 30, 2025 | -6.1% | −35.7 |
| Q2 FY2025 | Jun 30, 2025 | -8.7% | −32.0 |
| Q1 FY2025 | Mar 31, 2025 | 37.2% | +26.6 |
| Q4 FY2024 | Dec 31, 2024 | -139.8% | −167.0 |
| Q3 FY2024 | Sep 30, 2024 | 29.6% | +4.4 |
| Q2 FY2024 | Jun 30, 2024 | 23.4% | −8.2 |
| Q1 FY2024 | Mar 31, 2024 | 10.6% | −25.7 |
| Q4 FY2023 | Dec 31, 2023 | 27.3% | −2.7 |
| Q3 FY2023 | Sep 30, 2023 | 25.2% | −7.7 |
| Q4 FY2022 | Dec 31, 2022 | 31.5% | −23.2 |
| Q3 FY2022 | Sep 30, 2022 | 36.3% | +7.3 |
| Q2 FY2022 | Jun 30, 2022 | 30.0% | +2.5 |
| Q1 FY2022 | Mar 31, 2022 | 32.9% | +8.7 |
| Q4 FY2021 | Dec 31, 2021 | 54.7% | +64.9 |
| Q3 FY2021 | Sep 30, 2021 | 29.0% | −20.6 |
| Q2 FY2021 | Jun 30, 2021 | 27.5% | −19.5 |
| Q1 FY2021 | Mar 31, 2021 | 24.2% | +19.9 |
| Q4 FY2020 | Dec 31, 2020 | -10.2% | +8.8 |
| Q3 FY2020 | Sep 30, 2020 | 49.6% | +54.2 |
| Q2 FY2020 | Jun 30, 2020 | 47.0% | +59.7 |
| Q1 FY2020 | Mar 31, 2020 | 4.3% | +395.9 |
| Q4 FY2019 | Dec 31, 2019 | -18.9% | −71.7 |
| Q3 FY2019 | Sep 30, 2019 | -4.6% | −57.3 |
| Q2 FY2019 | Jun 30, 2019 | -12.7% | −71.3 |
| Q1 FY2019 | Mar 31, 2019 | -391.6% | −442.3 |
| Q4 FY2018 | Dec 31, 2018 | 52.8% | +15.3 |
| Q3 FY2018 | Sep 30, 2018 | 52.7% | −0.7 |
| Q2 FY2018 | Jun 30, 2018 | 58.6% | +0.7 |
| Q1 FY2018 | Mar 31, 2018 | 50.6% | +0.9 |
| Q4 FY2017 | Dec 31, 2017 | 37.5% | −19.5 |
| Q3 FY2017 | Sep 30, 2017 | 53.4% | +1.5 |
| Q2 FY2017 | Jun 30, 2017 | 57.8% | +5.9 |
| Q1 FY2017 | Mar 31, 2017 | 49.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 57.0% | – |
| Q3 FY2016 | Sep 30, 2016 | 51.9% | – |
| Q2 FY2016 | Jun 30, 2016 | 51.9% | – |
See a number that looks wrong?